203 related articles for article (PubMed ID: 32103587)
1. Histologically low-grade, yet biologically high-grade, canine cutaneous mast cell tumours: A systematic review and meta-analysis of individual participant data.
Bae S; Milovancev M; Bartels C; Irvin VL; Tuohy JL; Townsend KL; Leeper H
Vet Comp Oncol; 2020 Dec; 18(4):580-589. PubMed ID: 32103587
[TBL] [Abstract][Full Text] [Related]
2. The impact of extirpation of non-palpable/normal-sized regional lymph nodes on staging of canine cutaneous mast cell tumours: A multicentric retrospective study.
Ferrari R; Marconato L; Buracco P; Boracchi P; Giudice C; Iussich S; Grieco V; Chiti LE; Favretto E; Stefanello D
Vet Comp Oncol; 2018 Dec; 16(4):505-510. PubMed ID: 29893066
[TBL] [Abstract][Full Text] [Related]
3. Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study.
Pizzoni S; Sabattini S; Stefanello D; Dentini A; Ferrari R; Dacasto M; Giantin M; Laganga P; Amati M; Tortorella G; Marconato L
Vet Comp Oncol; 2018 Mar; 16(1):28-36. PubMed ID: 28233400
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic impact of regional lymphadenectomy in canine stage II cutaneous mast cell tumours.
Marconato L; Polton G; Stefanello D; Morello E; Ferrari R; Henriques J; Tortorella G; Benali SL; Bergottini R; Vasconi ME; Annoni M; Sabattini S
Vet Comp Oncol; 2018 Dec; 16(4):580-589. PubMed ID: 30047226
[TBL] [Abstract][Full Text] [Related]
5. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival.
Krick EL; Billings AP; Shofer FS; Watanabe S; Sorenmo KU
Vet Comp Oncol; 2009 Jun; 7(2):130-8. PubMed ID: 19453367
[TBL] [Abstract][Full Text] [Related]
6. Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumours.
Moore AS; Frimberger AE; Taylor D; Sullivan N
Vet Comp Oncol; 2020 Sep; 18(3):402-408. PubMed ID: 31916687
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-guided cytology of spleen and liver: a prognostic tool in canine cutaneous mast cell tumor.
Stefanello D; Valenti P; Faverzani S; Bronzo V; Fiorbianco V; Pinto da Cunha N; Romussi S; Cantatore M; Caniatti M
J Vet Intern Med; 2009; 23(5):1051-7. PubMed ID: 19656285
[TBL] [Abstract][Full Text] [Related]
8. Canine cutaneous and subcutaneous mast cell tumours: a narrative review.
Bellamy E; Berlato D
J Small Anim Pract; 2022 Jul; 63(7):497-511. PubMed ID: 34671978
[TBL] [Abstract][Full Text] [Related]
9. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
Taylor F; Gear R; Hoather T; Dobson J
J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgery.
Marconato L; Stefanello D; Kiupel M; Finotello R; Polton G; Massari F; Ferrari R; Agnoli C; Capitani O; Giudice C; Aresu L; Vasconi ME; Rigillo A; Sabattini S
Vet Comp Oncol; 2020 Sep; 18(3):409-415. PubMed ID: 31930651
[TBL] [Abstract][Full Text] [Related]
11. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous mastocytosis in 8 young dogs and review of literature.
Yang C; Bradley CW; Preziosi D; Mauldin EA
Vet Pathol; 2023 Nov; 60(6):849-856. PubMed ID: 37222130
[TBL] [Abstract][Full Text] [Related]
13. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001).
Gieger TL; Théon AP; Werner JA; McEntee MC; Rassnick KM; DeCock HE
J Vet Intern Med; 2003; 17(5):687-92. PubMed ID: 14529136
[TBL] [Abstract][Full Text] [Related]
14. Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours.
Murphy S; Sparkes AH; Blunden AS; Brearley MJ; Smith KC
Vet Rec; 2006 Mar; 158(9):287-91. PubMed ID: 16517820
[TBL] [Abstract][Full Text] [Related]
15. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis.
Chaffin K; Thrall DE
Vet Radiol Ultrasound; 2002; 43(4):392-5. PubMed ID: 12175005
[TBL] [Abstract][Full Text] [Related]
16. Histologic grade has a higher-weighted value than nodal status as predictor of outcome in dogs with cutaneous mast cell tumours and overtly metastatic sentinel lymph nodes.
Guerra D; Faroni E; Sabattini S; Agnoli C; Chalfon C; Stefanello D; Del Magno S; Cola V; Grieco V; Marconato L
Vet Comp Oncol; 2022 Sep; 20(3):551-558. PubMed ID: 35195937
[TBL] [Abstract][Full Text] [Related]
17. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
18. Mast cells and canine mast cell tumours. A review.
Misdorp W
Vet Q; 2004 Dec; 26(4):156-69. PubMed ID: 15663212
[TBL] [Abstract][Full Text] [Related]
19. Lymphadenectomy improves outcome in dogs with resected Kiupel high-grade cutaneous mast cell tumours and overtly metastatic regional lymph nodes.
Chalfon C; Sabattini S; Finotello R; Faroni E; Guerra D; Pisoni L; Ciammaichella L; Vasconi ME; Annoni M; Marconato L
J Small Anim Pract; 2022 Sep; 63(9):661-669. PubMed ID: 35733233
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997-2007).
Hume CT; Kiupel M; Rigatti L; Shofer FS; Skorupski KA; Sorenmo KU
J Am Anim Hosp Assoc; 2011; 47(1):37-44. PubMed ID: 21164163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
